Engene Holdings Inc (ENGN)

$9

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $8.53
    $9.75
    $9.00
    downward going graph

    5.22%

    Downside

    Day's Volatility :12.51%

    Upside

    7.69%

    downward going graph
  • $6.69
    $43.00
    $9.00
    downward going graph

    25.67%

    Downside

    52 Weeks Volatility :84.44%

    Upside

    79.07%

    downward going graph

Returns

PeriodEngene Holdings IncIndex (Russel 2000)
3 Months
-41.94%
0.0%
6 Months
16.73%
0.0%
1 Year
-55.0%
0.0%
3 Years
-55.0%
-20.2%

Highlights

Market Capitalization
397.5M
Book Value
$5.5
Earnings Per Share (EPS)
-2.61
Wall Street Target Price
32.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-29.38%
Return On Equity TTM
-330.6%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-44.5M
Diluted Eps TTM
-2.61
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.49
EPS Estimate Next Year
-1.58
EPS Estimate Current Quarter
-0.26
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Engene Holdings Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 261.11%

Current $9.00
Target $32.50

Technicals Summary

Sell

Neutral

Buy

Engene Holdings Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Engene Holdings Inc
Engene Holdings Inc
12.5%
16.73%
-55.0%
-55.0%
-55.0%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Engene Holdings Inc
Engene Holdings Inc
NA
NA
NA
-1.49
-3.31
-0.29
NA
5.5
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Engene Holdings Inc
Engene Holdings Inc
Buy
$397.5M
-55.0%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Company Information

Organization
Engene Holdings Inc
Employees
31
CEO
Mr. Jason D. Hanson Esq., J.D.
Industry
Miscellaneous

FAQs